(Q51396268)

4 April 2018

title

The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT(1B/1D) receptor agonist. (English)

1 reference

4 April 2018

1 reference

Gupta P

1

1 reference

4 April 2018

Butler P

series ordinal

2

1 reference

4 April 2018

Shepperson NB

series ordinal

3

1 reference

4 April 2018

McHarg A

series ordinal

4

1 reference

4 April 2018

language of work or name

English

0 references

publication date

1 June 2000

1 reference

4 April 2018

European Journal of Pharmacology

published in

1 reference

4 April 2018

volume

398

1 reference

4 April 2018

issue

1

1 reference

4 April 2018

page(s)

73-81

1 reference

4 April 2018

Migraine with aura shows gadolinium enhancement which is reversed following prophylactic treatment

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

5-Hydroxytryptamine-induced contractions of the human isolated saphenous vein: involvement of 5-HT2 and 5-HT1D-like receptors, and a comparison with grafted veins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetized dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Clinical and experimental effects of sumatriptan in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

The in vivo pharmacological profile of a 5-HT1 receptor agonist, CP-122,288, a selective inhibitor of neurogenic inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Characterisation of the contractile activity of eletriptan at the canine vascular 5-HT1B receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Time-dependent blockade of neurogenic plasma extravasation in dura mater by 5-HT1B/D agonists and endopeptidase 24.11.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Sumatriptan is a Potent Vasoconstrictor of Human Dural Arteries Via a 5-HT1-Like Receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Human arterial constrictor serotonin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. 5-HT1-like receptors resemble cloned 5-HT1D beta receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Blockade by oral or parenteral RPR 100893 (a non-peptide NK1 receptor antagonist) of neurogenic plasma protein extravasation within guinea-pig dura mater and conjunctiva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Differential distribution of 5HT1D- and 5HT1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Human isolated coronary artery contraction to sumatriptan: a post hoc analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Endothelin antagonist bosentan blocks neurogenic inflammation, but is not effective in aborting migraine attacks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Hemodynamic and coronary effects of intravenous eletriptan, a 5HT1B/1D-receptor agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Adverse reactions attributed to sumatriptan. A postmarketing study in general practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Sumatriptan contracts large coronary arteries of beagle dogs through 5-HT1-like receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Ergot alkaloids block neurogenic extravasation in dura mater: proposed action in vascular headaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Porcine carotid vascular effects of eletriptan (UK-116,044): a new 5-HT1B/1D receptor agonist with anti-migraine activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

Coronary vasospasm induced by subcutaneous sumatriptan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900240-5

10.1016/S0014-2999(00)00240-5

7 January 2021

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018